Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22COVID%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22COVID%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&lookfor=%22COVID%22&type=Subject
PubPharm (1.862)
1
Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster : Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster Following Primary Vaccination of Either Inactivated or mRNA or Viral Vector COVID-19 Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Phase II Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) : A Single-center, Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Booster Vaccination of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) in Healthy People Aged 18 Years and Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination : A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C) in Booster Vaccination in Healthy Population 18 Years Old of Age and Above
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19 : An International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel, Phase II Pilot Study to Evaluate the Efficacy and Safety of Recombinant Super-compound Interferon (rSIFN-co) Among Healthy Subjects in Close Contact With Confirmed COVID-19 Case(s) and Subjects With Mild or Asymptomatic COVID-19
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID : Placebo-Controlled, Randomized Trial of Ensitrelvir (S-217622) for Viral Persistence and Inflammation in People Experiencing Long COVID (PREVAIL-LC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise : A Phase 2A Randomized, Placebo-Controlled Study of Intravenous Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
"Efesovir" (FS-1) for COVID-19, Phase 2 : Randomized Controlled Open Study of Safety and Preliminary Efficiency of the Drug "Efesovir" (Oral Solution) for Coronavirus Infection (COVID-19)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID : A Prospective, Double-blind, Randomized, Parallel Group, Placebo Controlled, Multicentre, Phase II Study to Investigate the Efficacy, GPCR Autoantibody Neutralizing Effect, Safety, and Tolerability of BC 007 in Participants With Long COVID
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) : Recombinant Human InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic PAtients With COVID-19 Infection - "ILIAD 7 Trial" Brazil Cohort
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) : A Multicenter, Randomized, Double-blinded Placebo-controlled Study of Recombinant Interleukin-7 (CYT107) for Immune Restoration of Hospitalized Lymphopenic Patients With Coronavirus COVID-19 Infection. US Oncology Cohort
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[187]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
1.862
Aufsätze
1.862
E-Artikel
1.862
E-Ressourcen
Zeitschriftentitel
948
ClinicalTrials.gov
914
WHO International Clinical Trials Registry Plat...
Thema
1.862
610
Phase: Phase 2
1.860
Study Type: Interventional
685
COVID-19
475
Recruitment Status: Not yet recruiting
400
Recruitment Status: Authorised-recruitment may ...
393
Recruitment Status: Completed
219
Recruitment Status: Recruiting
158
Medical Condition: COVID-19
150
Recruitment Status: Terminated
101
Coronavirus Infections
94
Recruitment Status: Active, not recruiting
87
Medical Condition: Covid19
86
Pneumonia
84
Recruitment Status: Withdrawn
53
Infections
47
Communicable Diseases
43
Acute Lung Injury
42
Respiratory Distress Syndrome, Newborn
40
Severe Acute Respiratory Syndrome
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
117
2024
420
2023
573
2022
492
2021
260
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.840
Englisch
16
Unbestimmt
2
Dänisch
2
Französisch
2
Italienisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...